The tax dispute between PT BSB and DGT highlights the complexity of fiscal treatment for biological assets in the pearl cultivation industry. The core issue emerged when the Respondent performed a positive fiscal correction on the Cost of Goods Sold (COGS) amounting to IDR 4,561,918,626.00 for the 2020 Fiscal Year. This correction was based on the argument that the purchase of materials or merchandise was not supported by competent evidence, sparking a debate on the application of Article 6 Paragraph (1) of the Income Tax Law regarding expenses for obtaining, collecting, and maintaining income (3M).
The conflict centered on the interpretation of financial report data and physical evidence. The DGT contended that the expenses were not documented properly because no corresponding purchase transactions were found in the general ledger. Conversely, PT BSB argued that the value did not represent new material purchases but rather the recognition of the acquisition cost of pearl snails (biological assets) that died, went missing, or were culled during the production process. The company emphasized that, for accounting purposes, the acquisition cost of snails was initially capitalized as an asset and only recognized as a COGS expense when the snails were no longer economically viable or deceased.
The Tax Court Judges provided a crucial legal perspective in resolving this case. The Judges held that in the cultivation industry, the death or loss of "broodstock" is an inherent business risk, and its expenditure is a valid 3M expense. Through a thorough examination, the Panel found the evidence presented by PT BSB—including facility photos, acquisition vouchers, and quarterly snail mortality journals—to be sufficient and competent. The Judges underscored that economic substance must prevail over administrative errors in filling out tax return forms.
An analysis of this decision shows that consistent internal documentation is key to winning deductibility disputes. For businesses in similar sectors, a clear distinction between asset capitalization and the timing of expense recognition is vital. This ruling serves as an important precedent that losses on professionally managed biological assets can be recognized as fiscal expenses as long as they are materially proven. In conclusion, the Panel of Judges overturned all of the Respondent's corrections because the Petitioner successfully proved that the costs were genuinely related to business activities.
A Comprehensive Analysis and the Tax Court Decision on This Dispute Are Available Here